Chronic Disease Risk
October 16, 2026
Written by
The Biograph Editorial Team
A routine blood test often includes markers for blood sugar, but two of the most common – fasting blood glucose and hemoglobin A1C – measure metabolic control through completely different lenses. Understanding how these numbers differ, where they can disagree, and why neither tells the complete story in isolation is fundamental to preventing chronic metabolic disease.
Fasting glucose vs. A1C: A point-in-time snapshot vs. three-month average
The primary distinction between fasting blood glucose and A1C comes down to time frame:
Fasting Blood Glucose: Measures the amount of free glucose circulating in your bloodstream after an overnight fast (typically 8 to 12 hours). It represents an acute, point-in-time snapshot. Because it is a real-time reading, it can be influenced by recent meal composition, poor sleep, acute stress, intense training, or even morning cortisol fluctuations.
Hemoglobin A1C (HbA1c): Measures the percentage of hemoglobin – the oxygen-carrying protein in red blood cells – that has become bound to glucose. Because red blood cells live for approximately 90 to 120 days, A1C generally reflects your rolling average blood glucose level over the preceding 2 to 3 months. It does not require fasting and remains unaffected by day-to-day lifestyle fluctuations.
Fasting glucose vs. A1C diagnostic ranges
Clinical guidelines define metabolic thresholds across both markers to classify normal function, prediabetes, and type 2 diabetes:
Category
Fasting Blood Glucose
Hemoglobin A1C
Optimal/Normal
70 - 99 mg/dL
4.0% - 5.6%
Prediabetes
100 - 125 mg/dL
5.7% - 6.4%
Diabetes
≥ 126 mg/dL
≥ 6.5%
Why your fasting glucose and A1C might not matc
It is common to see a normal fasting glucose alongside an elevated A1C, or vice versa. Several physiological factors explain this discordance:
Postprandial spikes: You may have normal baseline fasting glucose in the morning, but experience significant post-meal blood sugar surges throughout the day that drive up your three-month A1C average.
Red blood cell turnover: Conditions that alter red blood cell lifespan, such as iron deficiency anemia, hemoglobin variants, or recent blood donation, can falsely skew A1C readings higher or lower independent of glycemic control.
Acute lifestyle variables: A high-carbohydrate late dinner, dehydration, or an acute illness can spike morning fasting glucose even if your long-term glycemic control is sound.
The missing link: Insulin resistance develops before blood sugar rises
While both fasting glucose and A1C are essential diagnostic tools, they are often late-stage indicators of metabolic dysfunction. The pancreas can overproduce insulin for years, or even decades, to force glucose into cells and maintain normal circulating blood sugar.
Over one in three adults have prediabetes, and the vast majority do not know it. By the time fasting blood sugar or A1C crosses clinical thresholds, significant insulin resistance and vascular stress are often already established.
How Biograph evaluates metabolic risk
At Biograph, blood sugar regulation is assessed as an integrated system rather than isolated numbers. We evaluate:
Paired fasting glucose and fasting insulin: Calculating HOMA-IR to measure early insulin resistance before glycemic thresholds breach.
Hemoglobin A1C: To track longitudinal glycemic trends over time.
Advanced body composition and visceral fat imaging: To evaluate deep abdominal and ectopic fat stores that drive systemic metabolic dysfunction.
This comprehensive approach helps detect metabolic shifts in their earliest, most modifiable stages, giving you clear, actionable steps to protect your long-term cardiometabolic health.
